Arcutis Biotherapeutics (ARQT) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $0.06.
- Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) rose 11818.18% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 7891.57%. This contributed to the annual value of -$1.16 for FY2024, which is 6937.16% up from last year.
- As of Q3 2025, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) stood at $0.06, which was up 11818.18% from -$0.13 recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) registered a high of $0.06 during Q3 2025, and its lowest value of -$1.89 during Q3 2022.
- In the last 5 years, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.76 in 2021 and averaged -$0.79.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 6710.53% in 2022, then skyrocketed by 11818.18% in 2025.
- Quarter analysis of 5 years shows Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) stood at -$1.43 in 2021, then rose by 20.28% to -$1.14 in 2022, then soared by 48.25% to -$0.59 in 2023, then surged by 84.88% to -$0.09 in 2024, then soared by 167.27% to $0.06 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.06 for Q3 2025, versus -$0.13 for Q2 2025 and -$0.2 for Q1 2025.